TCM
INFI

Tradewinds Capital Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Tradewinds Capital Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-29,000
Closed -$65K – 869
2021
Q4 		$65K Buy
29,000
+19,000
+190% +$47.7K 0.01% 227
2021
Q3 		$34K Buy
+10,000
New +$30.8K 0.01% 296

Other funds holding INFI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Tradewinds Capital Management's INFI Position: Q1 2022 in Review

Tradewinds Capital Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2022, closing a stake of 29,000 shares — an estimated $65K sold.

Tradewinds Capital Management first reported a position in INFI in Q3 2021 and held it in 2 quarters. The position peaked at $65K in Q4 2021. 93 funds tracked by Wall St. Rank hold INFI as of Q1 2022.

  • Tradewinds Capital Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2022 after selling out during the quarter.
  • Tradewinds Capital Management sold 29,000 Infinity Pharmaceuticals, Inc. shares in Q1 2022, an estimated $65K.
  • Tradewinds Capital Management first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2021 and held it in 2 quarters.
  • Tradewinds Capital Management's Infinity Pharmaceuticals, Inc. position peaked at $65K in Q4 2021.
  • 93 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2022.

Based on Tradewinds Capital Management's 13F filing for Q1 2022, filed 25 Apr 2022.